HIGHLIGHTS
- who: . and colleagues from the Carol Davila University of Medicine and Fudan University, China have published the research work: Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease, in the Journal: (JOURNAL)
- what: This study provides a theoretical basis for three ongoing phase 3 trials (NCT04197479, NCT04951219, NCT03900429) to further evaluate the efficacy and safety of resmetirom in the treatment of NAFLD (Harrison et_al, 2019). The authors focused on the role of carbohydrate and lipid metabolism, lipotoxicity, cell death, inflammation, and fibrosis as potential therapeutic targets for NAFLD.
- how: The results showed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.